APA (7th ed.) Citation

Sophie Marbaix, Annick Mignon, Audrey Taelman, Ahuva Averin, Mark Atwood, & Jeffrey Vietri. (2023). Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Sophie Marbaix, Annick Mignon, Audrey Taelman, Ahuva Averin, Mark Atwood, and Jeffrey Vietri. Cost-utility of 20-valent Pneumococcal Conjugate Vaccine Compared to No Vaccination and Recommended Alternative Vaccines Among Belgian Adults. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Sophie Marbaix, et al. Cost-utility of 20-valent Pneumococcal Conjugate Vaccine Compared to No Vaccination and Recommended Alternative Vaccines Among Belgian Adults. Taylor & Francis Group, 2023.